This Article  • PDF of this Correction  • Original article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Omitted Financial Disclosure in: Decreased -Amyloid_1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease

JAMA. 2007;298:1516.

Omitted Financial Disclosure: In the Original Contribution entitled "Decreased -Amyloid_1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease" published in the April 23/30, 2003, issue of JAMA (2003;289[16]:2094-2103), the following financial disclosure should have been published. Dr Sunderland reports having received honoraria from and/or consulting for Quintiles, Pfizer, Abbott, Alza, Novartis, Lundbeck, AstraZeneca, and CNS.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?